COSCIENS BIOPHARMA INC financial statements, including revenue, expenses, profit, and loss

The total revenue of CSCI for the last quarter is 3.20 M CAD, and it's 59181.48% higher compared to the previous quarter. The net income of Q2 24 is -1.95 M CAD.